Market Overview

Morning Market Movers

Share:
Related ALNY
Chardan Analysts Initiate Coverage On Akari Therapeutics With A Sell Rating
Arbutus Biopharma Taken Off Of Chardan's Sell List
More Data From Alnylam Pharmaceuticals, But Not Much More Clarity (Seeking Alpha)
Related MRK
Can Keytruda Deliver Earnings Growth For Merck?
Merck Gets Breakthrough Therapy Status From FDA And PRIME Status From EMA For Investigational Ebola Zaire Vaccine
Residential REITs Replace Diversified Dogs Atop Real Estate Sector Household In July (Seeking Alpha)

Alnylam Pharmaceuticals (NASDAQ: ALNY) rose 34.16% to $88.83 after the company reported that it has acquired investigational RNAi Therapeutic assets from Merck (NYSE: MRK). Genzyme and Alnylam expanded their collaboration on rare genetic diseases.

Rexahn Pharmaceuticals (NYSE: RNN) jumped 33.77% to $1.53. Rexahn Pharmaceuticals shares have jumped 235.29% over the past 52 weeks, while the S&P 500 index has gained 25.27% in the same period.

Rosetta Genomics (NASDAQ: ROSG) moved up 33.23% to $4.25 after the company reported that it has signed a master service provider agreement with a major global biopharmaceutical company.

Teche Holding Company (NYSE: TSH) shares jumped 28.44% to $70.00 after IBERIABANK (NASDAQ: IBKC) announced an agreement to acquire Teche Holding.

Posted-In: market moversNews Intraday Update Markets Movers

 

Related Articles (ALNY + IBKC)

View Comments and Join the Discussion!